In 2023, two novice business owners bought the former Moxie Java and completely reinvented it. Now their attention to day-to-day operations, friendly vibe and famed Pop-Tarts are helping them thrive.
The race will be contested on a temporary 2.73-mile track on the streets winding around AT&T Stadium and Globe Life Field.
Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, today announced that it has filed a class action lawsuit against Defendants Picard ...
While Anthropic’s Claude Code grabbed headlines, IBM has been deploying its own generative AI solution, Watsonx Code Assistant for Z, designed to modernize the very mainframes it built. Unlike general ...
In other findings in the report: 18% had already adopted Java Development Kit (JDK) 25, the most recent Long Term Support (LTS) release, which became available in September 2025. 64% said more than ...
EverythingLubbock.com on MSN

KLBK Tuesday AM Weather Update (3/11/26)

Tuesday's highs will vary from the upper 70s to the low 90s.
Yale University said it has barred professor David Gelernter from teaching computer science classes, for now, as the university conducts a review of his contact with Jeffrey Epstein, which included ...
EverythingLubbock.com on MSN

KLBK Monday AM Weather Update (3/7/26)

Highs Monday will range from the low 80s to the low 90s.
A little more than a year ago, on a trip to Nairobi, Kenya, some colleagues and I met a 12-year-old Masai boy named Richard Turere, who told us a fascinating story. His family raises livestock on the ...
Every new document, every refusal to answer questions, and every redacted name makes it clearer that Epstein did not operate in the shadows by accident. He thrived because the institutions meant to ...
Here’s who has resigned, is being investigated or is experiencing other consequences. By Karen Yourish, Lazaro Gamio and Amy Schoenfeld Walker The Justice Department’s latest release of files related ...
Enliven Therapeutics Inc. (Nasdaq: ELVN) reported this week that as of the end of 2025, the clinical-stage precision oncology ...